MEDI.OLライブシグナル | Getagraph.comで利益を最大化

買う 15415 min ago

@ NOK185.50

発行日: 15 4月 2024 @ 23:25

リターン: -6.20%

前回のシグナル: 4月 15 - 20:04

前回のシグナル: 売る

リターン: -3.64 %

Live Chart Being Loaded With Signals

Commentary (25 4月 2024 @ 23:29):

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally...

Stats
本日の出来高	29 751.00
平均出来高	5 242.00
時価総額	3.18B
EPS	NOK0 ( 2024-04-24 )
Last Dividend	NOK4.50 ( 2023-04-25 )
Next Dividend	NOK0 ( N/A )
P/E	30.74
ATR14	NOK1.384 (0.81%)

Medistim ASA 相関

10 最も正の相関
TECH.OL	0.929
ANDF.OL	0.927
KOMPL.OL	0.926
ELIMP.OL	0.915
ASA.OL	0.913
QFUEL.OL	0.909
AUTO.OL	0.909
NEL.OL	0.9
VEI.OL	0.898
BONHR.OL	0.896

10 最も負の相関
ODL.OL	-0.917
HAFNI.OL	-0.906
EQNR.OL	-0.904
FROY.OL	-0.898
SBX.OL	-0.889
WWI.OL	-0.876
SNI.OL	-0.861
EIOF.OL	-0.857
AKRBP.OL	-0.857
REACH.OL	-0.855

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Medistim ASA 財務諸表

Annual	2023
収益:	NOK526.36M
総利益:	NOK227.83M (43.28 %)
EPS:	NOK5.68

Q4	2023
収益:	NOK135.62M
総利益:	NOK48.41M (35.69 %)
EPS:	NOK1.050

Q3	2023
収益:	NOK124.10M
総利益:	NOK101.75M (81.99 %)
EPS:	NOK1.430

Q2	2023
収益:	NOK137.39M
総利益:	NOK107.49M (78.24 %)
EPS:	NOK1.800

Financial Reports:

No articles found.

Medistim ASA Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK4.50 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)

Medistim ASA Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.40 - Stable (11.99%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	NOK0.280	2005-04-29
Last Dividend	NOK4.50	2023-04-25
Next Dividend	NOK0	N/A
Payout Date	2023-05-05
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	NOK28.30	--
Avg. Dividend % Per Year	0.96%	--
Score	3.39	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.40
Div. Directional Score	7.73	--

Next Divdend (Est)
(2025-04-04)

NOK4.94 Estimate 3.12 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.39

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2005	NOK0.280	2.98%
2006	NOK0.270	2.05%
2007	NOK0.400	2.42%
2008	NOK0.500	2.63%
2009	NOK0.600	3.90%
2010	NOK0.150	0.64%
2011	NOK0.150	0.60%
2012	NOK1.000	4.35%
2013	NOK1.100	5.50%
2014	NOK0.800	3.48%
2015	NOK1.400	4.67%
2016	NOK1.650	3.06%
2017	NOK1.750	2.27%
2018	NOK2.00	2.78%
2019	NOK2.25	3.37%
2020	NOK2.75	1.42%
2021	NOK3.00	1.20%
2022	NOK3.75	0.96%
2023	NOK4.50	1.93%
2024	NOK0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
ALNG.OL	Dividend King	2023-11-27	Quarterly	2	6.60%	7.04
OKEA.OL	Dividend Knight	2023-12-01	Quarterly	3	5.65%	6.86
SALM.OL	Dividend Knight	2023-06-09	Annually	17	2.80%	4.97
BWLPG.OL	Dividend Knight	2023-11-17	Quarterly	11	1.68%	4.46
ELK.OL	Dividend Knight	2023-05-02	Annually	6	6.64%	4.31
BWO.OL	Dividend Knight	2023-11-20	Quarterly	14	0.87%	3.96
ATEA.OL	Dividend Knight	2023-11-20	Annually	16	2.97%	3.45
HAFNI.OL	Dividend Knight	2023-11-23	Semi-Annually	5	1.18%	3.31
AKER.OL	Dividend Knight	2023-11-07	Semi-Annually	20	2.99%	3.13
AUSS.OL	Dividend Knight	2023-05-26	Annually	17	3.23%	2.93

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.197	1.500	6.06	9.08	[0 - 0.5]
returnOnAssetsTTM	0.205	1.200	3.16	3.79	[0 - 0.3]
returnOnEquityTTM	0.272	1.500	8.09	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	4.15	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.68	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.632	1.500	2.04	3.07	[0.2 - 2]
debtRatioTTM	0.0349	-1.500	9.42	-10.00	[0 - 0.6]
interestCoverageTTM	14.67	1.000	5.68	5.68	[3 - 30]
operatingCashFlowPerShareTTM	6.34	2.00	7.89	10.00	[0 - 30]
freeCashFlowPerShareTTM	5.44	2.00	7.28	10.00	[0 - 20]
debtEquityRatioTTM	0.0443	-1.500	9.82	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.686	1.000	1.903	1.903	[0.2 - 0.8]
operatingProfitMarginTTM	0.250	1.000	7.01	7.01	[0.1 - 0.6]
cashFlowToDebtRatioTTM	6.57	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.041	0.800	6.39	5.12	[0.5 - 2]
Total Score				11.06

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	30.64	1.000	7.01	0	[1 - 100]
returnOnEquityTTM	0.272	2.50	8.77	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	5.44	2.00	8.19	10.00	[0 - 30]
dividendYielPercentageTTM	2.59	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	6.34	2.00	7.89	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.944	1.500	-9.63	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.220	1.000	7.00	0	[0.1 - 0.5]
Total Score				4.40

Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.